RemeGen Co., Ltd. reported a minor adjustment to its share capital after buying back 13,000 A-shares on 30 July 2026 through centralized price bidding on the Shanghai Stock Exchange.

The repurchase, carried out at prices ranging from RMB 109.00 to RMB 109.99 per share and averaging RMB 109.86, amounted to a total consideration of RMB 1.43 million. The shares have been moved into treasury for use under the company’s employee equity incentive scheme; any portion not allotted within three years will be cancelled.

Following the transaction, the number of issued shares (excluding treasury shares) dropped from 355.70 million to 355.69 million, a decrease of 0.0037%. Treasury shares increased from 194,144 to 207,144, while the company’s total issued share capital remained unchanged at 355.90 million.

No additional redemptions, cancellations, or on-market sales of treasury shares were disclosed in the filing.